PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
Sunshine Guojian Releases 2026 Interim Report:
Innovation-driven, Steady Advancement ...
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 ...
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Angel Yeast's AHH Packaging Design Recognized with Red Dot Award
SHANGHAI , Aug. 20, 2026 /PRNewswire/ -- Angel Nutritech, a professional yeast biotechnology subsidiary under Angel Yeast (SSE: 600298), has been recognized for its Angel Human Health (AHH) yeast essence ...
2026-08-21T    Biotechnology   Food/Beverages   Health Care/Hospital 
Matwings Demonstrates Closed-Loop Protein AI Through Four AI-Wet Lab Cycles and 222 Protein Variants
The GenSci148 program illustrates a shift from one-time mutation prediction to iterative protein engineering under real drug-development constraints ...
2026-08-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ISoOR 2026 Organoid Clinical Transformation Summit convened in Hangzhou
ICORE launched; nine companies joined as founding members ...
2026-08-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
MELBOURNE, Australia and INDIANAPOLIS , Aug. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended ...
2026-08-20T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer
oncoReveal® Essential+ validated at LSI Medience for cfDNA/cfRNA screening in the LC-SCRUM-Asia project, with testing planned to begin in August 2026 ...
2026-08-20T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
XtalPi Holdings Announces 2026 Interim Results
SHENZHEN, China , Aug. 19, 2026 /PRNewswire/ --  ...
2026-08-19T    Biotechnology   Medical/Pharmaceuticals 
Sisram Medical Delivers Solid 2026 Interim Results
Injectables Business Fuels Rapid Growth as APAC Drives International Revenue Expansion ...
2026-08-19T    Biotechnology   Cosmetics & Personal Care   Medical/Pharmaceuticals 
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui" or "the Company") today announced its financial results for the first half of 2026. During the reporting period, ...
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.